|
End-of-day quote
Nasdaq
11/09/2026
|
5-day change | 1st Jan Change | ||
| 1.800 USD | +1.69% |
|
-1.10% | -80.07% |
| 08/09 | EnGene Therapeutics Inc. Provides Clinical Updates | CI |
| 08/09 | EnGene Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2026 | CI |
| Market Cap | 121M 104M 98.37M 89.16M 167M 11.52B 168M 1.17B 449M 5.86B 453M 443M 18.52B | P/E 2026 * |
-0.99x | P/E 2027 * | -1.16x |
|---|---|---|---|---|---|
| Enterprise Value | -90.67M -78.12M -73.97M -67.05M -126M -8.66B -126M -879M -338M -4.41B -341M -333M -13.93B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | -4.22x |
| Free-Float |
99.9% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ENGN | End-of-day quote | |
CBOE
| ENGN | Real-time | |
|
Deutsche Boerse AG
| S0N0 | Delayed |
Last Transcript : enGene Therapeutics Inc.
| 1 day | +1.69% | ||
| 1 week | -1.10% | ||
| Current month | -2.17% | ||
| 1 month | +5.88% | ||
| 3 months | +11.11% | ||
| 6 months | -75.34% | ||
| Current year | -80.07% |
| 1 week | 1.76 |  | 1.94 |
| 1 month | 1.66 | | 1.95 |
| Current year | 1.4 | | 12.25 |
| 1 year | 1.4 | | 12.25 |
| 3 years | 1.4 | | 47.17 |
| 5 years | 1.4 | | 47.17 |
| 10 years | 1.4 | | 47.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ronald Cooper
CEO | Chief Executive Officer | 63 | 22/07/2024 |
Anthony Cheung
CTO | Chief Tech/Sci/R&D Officer | 55 | 24/04/2023 |
Kathleen Richton
DFI | Director of Finance/CFO | 48 | 16/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Gerry Brunk
BRD | Director/Board Member | 57 | 08/08/2023 |
Lota Zoth
BRD | Director/Board Member | 66 | 18/12/2023 |
Paul Hastings
BRD | Director/Board Member | 66 | 15/05/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/7/26 | Other | Interim Chief Business Officer | 75,000 | 0.1120% | ||
| 16/7/26 | Other | Chief Financial Officer | 0 | 0% | ||
| 16/7/26 | Other | Chief Financial Officer | 170,800 | 0.2550% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.69% | -1.10% | -68.48% | -83.49% | 121M | |
| -2.11% | -1.68% | +43.40% | +95.27% | 66.93B | |
| -0.23% | -4.45% | +32.50% | +75.75% | 61.97B | |
| +1.67% | +2.47% | -11.32% | +380.54% | 28.26B | |
| -1.05% | -4.43% | +28.84% | +10.59% | 24.59B | |
| +0.34% | -6.78% | -0.01% | -16.35% | 24.3B | |
| +0.43% | -3.37% | +16.22% | -17.99% | 19.41B | |
| -3.03% | -2.29% | +181.72% | +335.27% | 16.77B | |
| -1.94% | -4.94% | -8.15% | +483.69% | 14.18B | |
| +3.24% | -0.31% | -7.34% | +880.45% | 14B | |
| Average | -0.10% | -2.76% | +20.74% | +214.37% | 27.05B | |
| Weighted average by Cap. | -0.56% | -2.83% | +31.21% | +170.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 6.17M 5.32M 5.03M 4.56M 8.56M 589M 8.6M 59.79M 22.99M 300M 23.17M 22.67M 948M |
| Net income | -125M -107M -102M -92.25M -173M -11.92B -174M -1.21B -465M -6.06B -469M -458M -19.16B | -122M -105M -99.34M -90.04M -169M -11.63B -170M -1.18B -454M -5.92B -457M -447M -18.7B |
| Net Debt | -211M -182M -172M -156M -293M -20.18B -295M -2.05B -787M -10.27B -793M -776M -32.44B | -147M -126M -120M -108M -203M -14.01B -204M -1.42B -546M -7.13B -551M -539M -22.52B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | USD 1.800 | +1.69% | 651,007 |
| 10/09/26 | USD 1.770 | -4.32% | 565,327 |
| 09/09/26 | USD 1.850 | -3.65% | 486,375 |
| 08/09/26 | USD 1.920 | +5.49% | 1,508,314 |
| 04/09/26 | USD 1.820 | -0.55% | 412,684 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ENGN Stock
Select your edition
All financial news and data tailored to specific country editions
